PLASMA-LIPID PEROXIDES IN CORONARY HEART-DISEASE

被引:0
作者
OEN, LH
UTOMO, H
SUYATNA, F
HANAFIAH, A
ASIKIN, N
机构
[1] UNIV INDONESIA,SCH MED,HARAPAN KITA JAKARTA,CTR CARDIAC,JAKARTA,INDONESIA
[2] UNIV INDONESIA,SCH MED,DEPT PHARMACOL,JAKARTA,INDONESIA
关键词
CORONARY HEART DISEASE; RISK FACTORS; FREE RADICAL; LIPID PEROXIDE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The relation between plasma lipid peroxide and coronary heart disease was investigated at Harapan Hospital in Kita Jakarta. Ninety-eight patients (83 males and 15 females), below 75 years old were included in the study. The samples consisted of 47 cases with angina and 22 cases with myocardial infarction which were proven to suffer from coronary atherosclerosis by the presence of clinical symptoms, ECG abnormalities, angiography and myocardial enzyme measurement. Controls were patients who did not show any abnormalities in the parameters used. Controls and patients were classified into several groups based on the presence or absence of risk factors (smoking, hypertension, diabetes mellitus, hyperlipidemia, obesity, family history). The results of the study showed that plasma lipid peroxide in patients with angina and myocardial infarction which were 3.26 +/- 1.07-mu-mol and 3.20 +/- 0.82-mu-mol/l, respectively, were significantly higher (p <0.05) than controls 2.50 +/- 0.45-mu-mol/l. There was no differences in total cholesterol, LDL and triglyceride contents between control and patients with coronary heart disease; whereas HDL cholesterol level was significantly higher in the patients with angina, 38.7 +/- 10.5 mg/dl vs 31.5 +/- 6.76 mg/dl in patients with myocardial infarction. Univariate analysis of various risk factors revealed a strong correlation between plasma lipid peroxide and the chance in developing coronary heart disease. The present study showed that plasma lipid peroxide was increased in coronary heart disease and that it might be used as a determinant in the assessment of the severity of the disease. An investigation on the effects of antioxidants in these patients is planned.
引用
收藏
页码:77 / 80
页数:4
相关论文
共 17 条
[1]  
ABERG A, 1983, BRIT HEART J, V49, P416, DOI 10.1136/hrt.49.5.416
[2]  
BREWER HB, 1989, AM J CARDIOL, V64, P86
[3]   SURVIVORSHIP PATTERNS IN THE POST-HOSPITAL PHASE OF MYOCARDIAL-INFARCTION [J].
DAVIS, HT ;
DECAMILLA, J ;
BAYER, LW ;
MOSS, AJ .
CIRCULATION, 1979, 60 (06) :1252-1258
[4]  
HALLIWELL B, 1985, FREE RADICAL BIO MED, P139
[5]  
JUDKINS MP, 1968, RADIOL CLIN N AM, V6, P467
[6]  
KANELL WB, 1976, AM J CARDIOL, V38, P46
[7]   LIPID-PEROXIDATION AND PROTECTIVE ENZYMES DURING THE COURSE OF MYOCARDIAL-INFARCTION [J].
LOEPER, J ;
GOY, J ;
BEDU, O ;
ROZENSZTAJN, L .
AGENTS AND ACTIONS, 1987, 22 (3-4) :340-342
[8]  
LOEPER J, 1983, IRCS MED SCI-BIOCHEM, V11, P1034
[9]   RELATION OF ANGIOGRAPHICALLY DEFINED CORONARY-ARTERY DISEASE TO PLASMA-LIPOPROTEIN SUBFRACTIONS AND APOLIPOPROTEINS [J].
MILLER, NE ;
HAMMETT, F ;
SALTISSI, S ;
RAO, S ;
VANZELLER, H ;
COLTART, J ;
LEWIS, B .
BRITISH MEDICAL JOURNAL, 1981, 282 (6278) :1741-1744
[10]  
NAKASHIMA T, 1984, BIOCH INT, V8, P501